160 related articles for article (PubMed ID: 37228679)
1. Design, synthesis, and characterization of non-hemolytic antimicrobial peptides related to human cathelicidin LL-37.
Krishnamoorthy R; Adhikari P; Anaikutti P
RSC Adv; 2023 May; 13(23):15594-15605. PubMed ID: 37228679
[TBL] [Abstract][Full Text] [Related]
2. Arginine-Containing Surfactant-Like Peptides: Interaction with Lipid Membranes and Antimicrobial Activity.
Castelletto V; Barnes RH; Karatzas KA; Edwards-Gayle CJC; Greco F; Hamley IW; Rambo R; Seitsonen J; Ruokolainen J
Biomacromolecules; 2018 Jul; 19(7):2782-2794. PubMed ID: 29738229
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37.
Thennarasu S; Tan A; Penumatchu R; Shelburne CE; Heyl DL; Ramamoorthy A
Biophys J; 2010 Jan; 98(2):248-57. PubMed ID: 20338846
[TBL] [Abstract][Full Text] [Related]
4. Characterizing the structure-function relationship reveals the mode of action of a novel antimicrobial peptide, P1, from jumper ant Myrmecia pilosula.
Tseng TS; Tsai KC; Chen C
Mol Biosyst; 2017 Jun; 13(6):1193-1201. PubMed ID: 28470277
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel N-terminal peptides of integrin and aminopeptidase are new finding for anticancer activity.
Krishnamoorthy R; Singh M; Anaikutti P; Paul L E; Dhanasekaran S; Sathiah T
Bioorg Chem; 2023 May; 134():106434. PubMed ID: 36863075
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics simulation of the membrane binding and disruption mechanisms by antimicrobial scorpion venom-derived peptides.
Velasco-Bolom JL; Corzo G; Garduño-Juárez R
J Biomol Struct Dyn; 2018 Jun; 36(8):2070-2084. PubMed ID: 28604248
[TBL] [Abstract][Full Text] [Related]
7.
Siano A; Humpola MV; de Oliveira E; Albericio F; Simonetta AC; Lajmanovich R; Tonarelli GG
Molecules; 2018 Nov; 23(11):. PubMed ID: 30423858
[TBL] [Abstract][Full Text] [Related]
8. Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents.
Tzitzilis A; Boura-Theodorou A; Michail V; Papadopoulos S; Krikorian D; Lekka ME; Koukkou AI; Sakarellos-Daitsiotis M; Panou-Pomonis E
J Pept Sci; 2020 Jul; 26(7):e3254. PubMed ID: 32567085
[TBL] [Abstract][Full Text] [Related]
9. Conformation and Orientation of Antimicrobial Peptides MSI-594 and MSI-594A in a Lipid Membrane.
Yang P; Guo W; Ramamoorthy A; Chen Z
Langmuir; 2023 Apr; 39(15):5352-5363. PubMed ID: 37017985
[TBL] [Abstract][Full Text] [Related]
10. Thermodynamics of the interactions of tryptophan-rich cathelicidin antimicrobial peptides with model and natural membranes.
Andrushchenko VV; Aarabi MH; Nguyen LT; Prenner EJ; Vogel HJ
Biochim Biophys Acta; 2008 Apr; 1778(4):1004-14. PubMed ID: 18222168
[TBL] [Abstract][Full Text] [Related]
11. Solid-state nuclear magnetic resonance relaxation studies of the interaction mechanism of antimicrobial peptides with phospholipid bilayer membranes.
Lu JX; Damodaran K; Blazyk J; Lorigan GA
Biochemistry; 2005 Aug; 44(30):10208-17. PubMed ID: 16042398
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of antibacterial action of dermaseptin B2: interplay between helix-hinge-helix structure and membrane curvature strain.
Galanth C; Abbassi F; Lequin O; Ayala-Sanmartin J; Ladram A; Nicolas P; Amiche M
Biochemistry; 2009 Jan; 48(2):313-27. PubMed ID: 19113844
[TBL] [Abstract][Full Text] [Related]
13. Dermaseptin S9, an alpha-helical antimicrobial peptide with a hydrophobic core and cationic termini.
Lequin O; Ladram A; Chabbert L; Bruston F; Convert O; Vanhoye D; Chassaing G; Nicolas P; Amiche M
Biochemistry; 2006 Jan; 45(2):468-80. PubMed ID: 16401077
[TBL] [Abstract][Full Text] [Related]
14. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles.
Wang G
J Biol Chem; 2008 Nov; 283(47):32637-43. PubMed ID: 18818205
[TBL] [Abstract][Full Text] [Related]
15. Molecular Dynamics Simulations of Human Antimicrobial Peptide LL-37 in Model POPC and POPG Lipid Bilayers.
Zhao L; Cao Z; Bian Y; Hu G; Wang J; Zhou Y
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652823
[TBL] [Abstract][Full Text] [Related]
16. Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae.
Barksdale SM; Hrifko EJ; van Hoek ML
Dev Comp Immunol; 2017 May; 70():135-144. PubMed ID: 28089718
[TBL] [Abstract][Full Text] [Related]
17. Bilayer interactions of indolicidin, a small antimicrobial peptide rich in tryptophan, proline, and basic amino acids.
Ladokhin AS; Selsted ME; White SH
Biophys J; 1997 Feb; 72(2 Pt 1):794-805. PubMed ID: 9017204
[TBL] [Abstract][Full Text] [Related]
18. Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides.
Tsai CW; Hsu NY; Wang CH; Lu CY; Chang Y; Tsai HH; Ruaan RC
J Mol Biol; 2009 Sep; 392(3):837-54. PubMed ID: 19576903
[TBL] [Abstract][Full Text] [Related]
19. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.
Wang G; Mishra B; Epand RF; Epand RM
Biochim Biophys Acta; 2014 Sep; 1838(9):2160-72. PubMed ID: 24463069
[TBL] [Abstract][Full Text] [Related]
20. Structures and mode of membrane interaction of a short alpha helical lytic peptide and its diastereomer determined by NMR, FTIR, and fluorescence spectroscopy.
Oren Z; Ramesh J; Avrahami D; Suryaprakash N; Shai Y; Jelinek R
Eur J Biochem; 2002 Aug; 269(16):3869-80. PubMed ID: 12180963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
